| Literature DB >> 18042886 |
Abstract
Pregabalin is a new synthetic molecule and a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid. It is an alpha2-delta (alpha2-delta) ligand that has analgesic, anticonvulsant, anxiolytic, and sleep-modulating activities. Pregabalin binds potently to the alpha2-delta subunit of calcium channels, resulting in a reduction in the release of several neurotransmitters, including glutamate, noradrenaline, serotonin, dopamine, and substance P. In this review, I will discuss the pharmacology of pregabalin and available efficacy studies in pain management. This review will focus on the advances in pregabalin pharmacology since my previous review in 2005.Entities:
Mesh:
Substances:
Year: 2007 PMID: 18042886 DOI: 10.1213/01.ane.0000287643.13410.5e
Source DB: PubMed Journal: Anesth Analg ISSN: 0003-2999 Impact factor: 5.108